How to optimize β-blocker therapy in heart failure patients complicating with chronic obstructive pulmonary disease?
10.3760/cma.j.cn112148-20191008-00620
- Author:
Xu Yu HE
1
;
Ze Jia WU
1
;
Li Wen LI
1
Author Information
1. Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.
- Publication Type:Journal Article
- MeSH:
Adrenergic beta-Antagonists;
Heart Failure/etiology*;
Humans;
Pulmonary Disease, Chronic Obstructive/complications*
- From:
Chinese Journal of Cardiology
2020;48(4):344-348
- CountryChina
- Language:Chinese
